Petco Health & Wellness Company, INC 8-K filings

Current reports — the filing a company makes when something happens that shareholders need to know about before the next quarterly report.

NASDAQ
Petco Health and Wellness Company, Inc. announced the appointment of Jeffrey Naylor, former CFO of The TJX Companies, to its Board of Directors and as Chair of the Audit Committee, effective August 1, 2026.
NASDAQ
Petco Health and Wellness Company, Inc. announced the resignation of its Chief Human Resources Officer, Holly May, for personal reasons, effective upon the completion of a transition period.
NASDAQ
Petco Health and Wellness Company, Inc. announced that its stockholders approved an amendment to its 2021 Equity Incentive Plan, increasing the number of shares reserved for issuance.
NASDAQ
Petco Health and Wellness Company, Inc. announced its first quarter 2026 financial results, showing a return to positive comparable sales growth and profitability exceeding expectations.
NASDAQ
Petco announced Glenn Murphy's transition to Chairman of the Board and the successful closing of its long-term debt refinancing.
NASDAQ
Petco Health and Wellness Company, Inc. has successfully refinanced $1.5 billion of existing term loans with a new $900 million term loan facility and $600 million in senior secured notes due 2031.
NASDAQ
Petco Health and Wellness Company, Inc. announced the pricing of $600 million in 8.250% senior secured notes due 2031 to refinance existing debt and for general corporate purposes.
NASDAQ
Petco Health and Wellness Company, Inc. announced an offering of $650 million in senior secured notes due 2031 to refinance existing debt and for general corporate purposes.
NASDAQ
Petco announced a debt refinancing initiative and reaffirmed its fourth quarter and full fiscal year 2025 financial guidance for Net Sales and Adjusted EBITDA.
NASDAQ
Petco Health and Wellness Company, Inc. reported third quarter 2025 financial results, exceeding profitability goals and upwardly revising its full year 2025 earnings guidance.
NASDAQ
Petco Health and Wellness Company, Inc. reported second quarter 2025 financial results, exceeding commitments and raising its full-year earnings outlook.
NASDAQ
Petco Health and Wellness Company, Inc. announced its participation in the 32nd Annual Goldman Sachs Global Retailing Conference on September 4, 2025.
NASDAQ
Petco Health and Wellness Company, Inc. announced that its stockholders approved the election of three Class II directors, the advisory compensation of named executive officers, and the ratification of Ernst & Young LLP as its independent auditor at the annual meeting.
NASDAQ
Petco Health and Wellness Company, Inc. reported first quarter 2025 financial results that surpassed earnings guidance, reaffirming its fiscal 2025 net sales and earnings outlook despite a slight decrease in net sales.
NASDAQ
Petco Health and Wellness Company, Inc. announced the resignation of Board Director Christy Lake, effective at the 2025 Annual Meeting of Stockholders, and a subsequent reduction in the Board's size to ten directors.
NASDAQ
Petco Health and Wellness Company, Inc. announced its Q4 and full year 2024 financial results, with expectations of double-digit Adjusted EBITDA growth in 2025.
NASDAQ
Petco Health and Wellness Company, Inc. announces the departure of Brian LaRose as CFO, with Sabrina Simmons stepping into the role, and details of LaRose's transition and separation agreement.
NASDAQ
Petco finalizes transition agreement with former CFO Brian LaRose, outlining separation payments and benefits following his departure.
NASDAQ
Petco appoints Sabrina Simmons as CFO and adds Michael Romanko and Jack Stout to its executive team to accelerate operational improvements and return to profitable growth.
NASDAQ
Petco's third quarter results show a slight increase in revenue and a significant reduction in net loss compared to the previous year, although the company still faces challenges.
NASDAQ
Petco's second quarter 2024 results show a slight revenue decrease and a net loss, but the company is focused on improving profitability and leveraging its strengths.
NASDAQ
Petco Health and Wellness Company has appointed Joel D. Anderson as CEO, succeeding R. Michael Mohan, who will now chair a newly formed Value Creation Committee, with adjustments made to his compensation.
NASDAQ
Petco's annual meeting resulted in the election of four Class I directors, approval of executive compensation, and ratification of Ernst & Young as the company's auditor.
NASDAQ
Petco has appointed Joel D. Anderson as its new CEO, effective July 29, 2024, succeeding interim CEO R. Michael Mohan.
NASDAQ
Petco has announced significant changes to its leadership team, including the elimination of the Chief Operating Officer role and the departure of the Chief Merchandising and Supply Chain Officer.
NASDAQ
Petco's first quarter 2024 results show a slight revenue decrease and a significant net loss, despite growth in consumables and services, as the company focuses on strategic repositioning.
NASDAQ
Petco has appointed Glenn Murphy as Executive Chairman of the Board and secured a $2.5 million investment through a private stock purchase agreement.
NASDAQ
Petco's Chief Customer Officer, Darren MacDonald, will be terminated effective April 12, 2024, without cause, triggering severance benefits.
NASDAQ
Petco appoints R. Michael Mohan as interim CEO, replacing Ron Coughlin, while also reporting a net loss for both Q4 and the full year 2023, impacted by a significant goodwill impairment.
NASDAQ
Petco's Chief Financial Officer, Brian LaRose, will participate in a fireside chat at the UBS Global Consumer and Retail Conference on March 14, 2024.